Figure 7.
The morphological changes of HepG2 cells, HT29 cells, MDD-MB231 cells, Chang cells, and HUVECs treated with iron–manganese-promoted sulfated zirconia nanoparticles at their respective IC50 concentrations for 72 hours..
Abbreviations: HUVEC, human umbilical vein endothelial cell; IC50, concentration of drug needed to inhibit cell growth by 50%; NPs, nanoparticles.
